Category: Data Driven Compliance

Explore our library of blogs, insights, research papers, and more information on compliance in the life sciences industry.

5 Must-Have Features to Conduct Effective HCP Debarment Screening

Effective HCP (Healthcare Professional) debarment screening is the backbone of compliance and risk management. As regulatory landscapes continuously evolve, it is becoming increasingly crucial to ensure that HCPs involved in your business are not debarred or excluded from federal health care programs. To avoid engagement of debarred HCPs, the debarment screening method is widely used […]

Real-Time T&E Monitoring: How Technology is Revolutionizing Compliance?

A high degree of fraud often occurs in the T&E area, making it a critical starting point for identifying non-compliance. However, conducting a 100% audit of expense data is challenging due to the sheer volume of transactions, the complexity of financial records, siloed systems, and the potential for human error or inconsistencies in data reporting. […]

How To Manage Expense Reporting Fraud Within Life Sciences? 

Expense report fraud is a big problem, especially in the life sciences industry where following rules and regulations is quite important. From falsified receipts to inflated claims, fraudulent expense reporting can have severe consequences.   As a compliance officer, it’s essential to have a robust compliance strategy to identify, reduce, and ultimately prevent such fraud. In […]

The Importance of Data-Driven Compliance in the Life Sciences Industry

The life sciences industry in the United States is a complex and heavily regulated sector. With the critical nature of its work, ensuring compliance with federal and state regulations is paramount. Life sciences companies dedicate 80% of their resources to making sense of data while realizing only 20% of its value in the form of […]

A Comprehensive Guide to Auditing Expense Reports for Life Sciences Companies

Organizations lose an estimated 5% of all revenue to fraud each year. According to the Association of Certified Fraud Examiners (ACFE), this translates to a global loss of $4.5 trillion annually. The fraud, misconduct, or errors when identified by the regulatory authorities can lead to financial penalties, legal repercussions, and reputational damage, further intensifying the […]

Understanding the Financial Thresholds in CMS Open Payments Data 2024

The CMS Open Payments Program requires life sciences companies to report payments and transfers of value to physicians, teaching hospitals, and other covered recipients to the Centers for Medicare and Medicaid Services (CMS). Out of the several critical aspects of this program, one is adhering to the de minimis rule for reporting spend data. For […]